Six distinct peroxiredoxin (Prx) proteins (Prx I-VI) from distinct genes ha
ve been identified in mammalian tissues. Prxs are members of a group of per
oxidases that have conserved reactive cysteine residue(s) in the active sit
e(s). An immediate physiological electron donor for the peroxidase catalysi
s for five Prx proteins (Prx I-V) has been identified as thioredoxin (Trx),
but that for Prx VI (I-Cys Prx) is still unclear. To identify an immediate
electron donor and a binding protein for Prx VI, we performed a Prx VI pro
tein overlay assay. A 20-kDa binding protein was identified by the Prx VI p
rotein overlay assay with flow-through fractions from a High-Q column with
rat lung crude extracts. Using matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF) and MS-Fit, we identified the
20-kDa Prx Vl-binding protein as a cyclophilin A (CyP-A). The binding of re
combinant human CyP-A (hCyP-A) to Prx VI was confirmed by using the hCyP-A
protein overlay assay and Western immunoblot analysis with hCyP-A-specific
antibodies. hCyP-A enhanced the antioxidant activity of Prx VI, as well as
the other known mammalian Prx isotypes. hCyP-A supported antioxidant activi
ty of Prx II and Prx VI both against thiol (dithiothreitol)-containing meta
l-catalyzed oxidation (MCO) systems and ascorbate-containing MCO systems. P
rx II was reduced by hCyP-A without help from any other reductant, and the
reduction was cyclosporin A-independent. These results strongly suggest tha
t CyP-A not only binds to Prx proteins but also supports its peroxidase act
ivity as an immediate electron donor. In addition, Cys(115) and Cys(161) of
hCyP-A were found to be involved in the activation and the reduction of Pr
x.